Month: March 2019

ZAMBIAN GOVERNMENT WELCOMES ADOLESCENT HIV PREVENTION STUDY FINDINGS As the HIV epidemic continues to take its toll on Zambia, a new HIV prevention study on young people has found that most Zambian adolescents are HIV negative, but more needs to…

Zambart is one of the study sites for a Phase IIb trial of a new TB vaccine. The trial is being conducted by Aeras and GlaxoSmithKline Vaccines, S.A. (GSK) and is a double-blind randomised, placebo controlled study. (Clinical Trail.gov Identifier:…

    Tuberculosis Reduction through Expanded Anti-Retroviral Treatment and Screening (TREATS) Project THE TREATS project (Tuberculosis Reduction through Expanded Anti-retroviral Treatment and Screening) aims to measure the impact of a household-level combined HIV and TB prevention intervention on the burden…

HIV Self-Testing Africa Project Zambart, is part of a consortium of partners conducting the four-year HIV Self-Testing Africa (STAR) Study in fourteen urban and rural communities in Zambia.  STAR is a three-country clinical research project comprising Zambia, Zimbabwe and Malawi,…